Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the pyrido[2,3-d]pyrimidines class of organic compounds. It has not been approved for clinical use and is considered experimental. There are no known indications or associated conditions for this drug in clinical trials or regulatory approvals. Its mechanism of action and biological targets have not been described in publicly available sources as of now. The compound is referenced in chemical databases such as DrugBank (DB07042), ChemSpider (ID: 25057480), and RCSB PDB (Ligand ID: 3BA)[1][5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide.